CRC tissue; normal (para-carcinoma) tissue; CRC xenograft tumors
CACO-2; HCT116; Lovo; SW620; SW480; RKO
cell line-derived xenograft
Notch (inhibits); proliferation (inhibits); migration (inhibits); invasion (inhibits); EMT (inhibits); m6A modification (other)
Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Transwell Assay; Western Blot; In Vivo Animal Model; H&E Staining; TUNEL
The study suggests circ_0000390 may provide a basis for diagnosis, therapy, and prognosis assessment of CRC, but no direct diagnostic or prognostic performance was reported.
hsa_circ_0000390 is downregulated in colorectal cancer tissues and functions as a tumor-suppressive circRNA. Its overexpression inhibits CRC cell proliferation, migration, invasion, EMT-related changes, and xenograft tumor growth, at least partly by reducing Notch1/Hes1 signaling; METTL3-mediated downregulation of circ_0000390 promotes malignant CRC phenotypes.
0.6285
METTL3-mediated Hsa_circ_0000390 downregulation enhances the proliferation, migration, and invasion of colorectal cancer cells by increasing Notch1 expression.
combined biological and clinical study